Christopher Upton

Array ( [id] => 5682901 [patent_doc_number] => 20060199171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Assays for TERT promoter modulatory agents' [patent_app_type] => utility [patent_app_number] => 11/349734 [patent_app_country] => US [patent_app_date] => 2006-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7118 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199171.pdf [firstpage_image] =>[orig_patent_app_number] => 11349734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5457850 [patent_doc_number] => 20090258002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Biomarkers for Tissue Status' [patent_app_type] => utility [patent_app_number] => 11/883535 [patent_app_country] => US [patent_app_date] => 2006-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 122677 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258002.pdf [firstpage_image] =>[orig_patent_app_number] => 11883535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6532551 [patent_doc_number] => 20100221349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'NUCLEIC ACID CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 11/815278 [patent_app_country] => US [patent_app_date] => 2006-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 43897 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221349.pdf [firstpage_image] =>[orig_patent_app_number] => 11815278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4703 [patent_doc_number] => 07816509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-19 [patent_title] => 'Translational elongation factor promoter from Pichia pastoris and method for producing recombinant protein using the same' [patent_app_type] => utility [patent_app_number] => 12/094138 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5710 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/816/07816509.pdf [firstpage_image] =>[orig_patent_app_number] => 12094138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693986 [patent_doc_number] => 20070015700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Mammalian genes modulated during fasting and feeding' [patent_app_type] => utility [patent_app_number] => 11/333773 [patent_app_country] => US [patent_app_date] => 2006-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 39168 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015700.pdf [firstpage_image] =>[orig_patent_app_number] => 11333773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776819 [patent_doc_number] => 20060105459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Transgenic mice containing NTTP1 phosphatase gene disruptions' [patent_app_type] => utility [patent_app_number] => 11/328541 [patent_app_country] => US [patent_app_date] => 2006-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19603 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20060105459.pdf [firstpage_image] =>[orig_patent_app_number] => 11328541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4988126 [patent_doc_number] => 20070154465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Stem cell therapy for retinal disease' [patent_app_type] => utility [patent_app_number] => 11/323714 [patent_app_country] => US [patent_app_date] => 2005-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6699 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154465.pdf [firstpage_image] =>[orig_patent_app_number] => 11323714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648382 [patent_doc_number] => 20060134114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Novel human kallikrein-like genes' [patent_app_type] => utility [patent_app_number] => 11/319952 [patent_app_country] => US [patent_app_date] => 2005-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 36177 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134114.pdf [firstpage_image] =>[orig_patent_app_number] => 11319952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 383116 [patent_doc_number] => 07307068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-11 [patent_title] => 'Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products' [patent_app_type] => utility [patent_app_number] => 11/312299 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7326 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/307/07307068.pdf [firstpage_image] =>[orig_patent_app_number] => 11312299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5303403 [patent_doc_number] => 20090298055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'PRODUCTION OF PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/720476 [patent_app_country] => US [patent_app_date] => 2005-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17577 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298055.pdf [firstpage_image] =>[orig_patent_app_number] => 11720476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5130728 [patent_doc_number] => 20070207125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Vascularized human skin equivalent' [patent_app_type] => utility [patent_app_number] => 11/273320 [patent_app_country] => US [patent_app_date] => 2005-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 37789 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207125.pdf [firstpage_image] =>[orig_patent_app_number] => 11273320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5807692 [patent_doc_number] => 20060094046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Compositions and methods relating to angiogenesis and tumorigenesis' [patent_app_type] => utility [patent_app_number] => 11/251687 [patent_app_country] => US [patent_app_date] => 2005-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14540 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094046.pdf [firstpage_image] =>[orig_patent_app_number] => 11251687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726357 [patent_doc_number] => 20060057117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Vascular endothelial growth factor 2' [patent_app_type] => utility [patent_app_number] => 11/249422 [patent_app_country] => US [patent_app_date] => 2005-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 62200 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057117.pdf [firstpage_image] =>[orig_patent_app_number] => 11249422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 307290 [patent_doc_number] => 07531356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Promoter sequences for corticotropin releasing-factor receptor CRF2α and method of identifying agents that alter the activity of the promoter sequences' [patent_app_type] => utility [patent_app_number] => 11/234916 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8445 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531356.pdf [firstpage_image] =>[orig_patent_app_number] => 11234916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814024 [patent_doc_number] => 20060084121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'OX2 receptor homologs' [patent_app_type] => utility [patent_app_number] => 11/233798 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33480 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084121.pdf [firstpage_image] =>[orig_patent_app_number] => 11233798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239388 [patent_doc_number] => 08604180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'DNA fragment having promoter function' [patent_app_type] => utility [patent_app_number] => 11/662358 [patent_app_country] => US [patent_app_date] => 2005-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10902 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11662358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880879 [patent_doc_number] => 20060029962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Assays for TERT promoter modulatory agents' [patent_app_type] => utility [patent_app_number] => 11/198933 [patent_app_country] => US [patent_app_date] => 2005-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12410 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029962.pdf [firstpage_image] =>[orig_patent_app_number] => 11198933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7246452 [patent_doc_number] => 20050272028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Myostatin and mimetics thereof' [patent_app_type] => utility [patent_app_number] => 11/190767 [patent_app_country] => US [patent_app_date] => 2005-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5244 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272028.pdf [firstpage_image] =>[orig_patent_app_number] => 11190767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4745620 [patent_doc_number] => 20080090222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Virus-Inactivated Hemoglobin And Method Of Producing The Same' [patent_app_type] => utility [patent_app_number] => 11/631347 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9071 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090222.pdf [firstpage_image] =>[orig_patent_app_number] => 11631347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5770585 [patent_doc_number] => 20050266479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Cloning, expression and characterization of the SPG4 gene responsible for the most common form of autosomal dominant spastic paraplegia' [patent_app_type] => utility [patent_app_number] => 11/155492 [patent_app_country] => US [patent_app_date] => 2005-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15680 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266479.pdf [firstpage_image] =>[orig_patent_app_number] => 11155492 [rel_patent_id] =>[rel_patent_doc_number] =>)